MedPath

Early Individualized-Exercise Based Cardiac Rehabilitation Programs in Patients With Acute Myocardial Infarction

Not Applicable
Conditions
Acute Myocardial Infarction
Interventions
Behavioral: Exercise-based cardiac rehabilitation
Registration Number
NCT04511182
Lead Sponsor
RenJi Hospital
Brief Summary

Acute myocardial infarction (AMI) is a life-threatening condition and a cause of functional disability. After reperfusion therapies and pharmacological strategies, patients suffered great pain physically and mentally. How to improve the quality of life and the prognosis in patients with AMI is a hot topic in the field of cardiac rehabilitation now. In this study, a randomized, controlled and prospective clinical trial is designed for patients with AMI to improve exercise capacity, cardiometabolic parameters, as well as quality of life by an individualized, low-cost exercise intervention we developed after evaluation by Cardiopulmonary Exercise Tests (CPET). Serial CPET are performed to prospectively measure changes in aerobic exercise capacity, and the MOS item short form health survey(SF-36)are constructed to survey life quality. What's more, echocardiography and NT-proBNP are also assessed.

Detailed Description

Acute myocardial infarction (AMI) is a life-threatening condition and a cause of functional disability, although reperfusion therapies and pharmacological strategies have been developed dramatically. Percutaneous coronary intervention(PCI)can effectively improve the myocardial blood supply of patients, However, various degrees of reduced exercise tolerance, anxiety and depression symptoms, impaired social function may occur after PCI and then lead to the decline of their quality of life. Exercise-based cardiopulmonary rehabilitation, which has beneficial effects on physical fitness, quality of life, cardiovascular risk factors and clinical outcome, is an important part of secondary prevention for patients after an acute myocardial infarction. Despite the evidence of these beneficial effects, cardiac rehabilitation programs are still largely underutilized and the exact benefits are still less well known. In this study, a randomized, controlled and prospective clinical trial is designed for patients with AMI to improve exercise capacity, cardiometabolic parameters, as well as quality of life by an individualized, low-cost exercise intervention we developed after evaluation by Cardiopulmonary Exercise Tests (CPET) . Serial CPET are performed to prospectively measure changes in aerobic exercise capacity, and the MOS item short form health survey(SF-36)are constructed to survey life quality. What's more, echocardiography and NT-proBNP are also assessed.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
160
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
exercise intervention groupExercise-based cardiac rehabilitationPatients will receive standard medications plus EBCR 。Education covering topics related to AMI and exercise for AMI will be implemented and any consultations on exercise prescription and disease management will be explained by a cardiac rehabilitation team consisting of cardiologists, cardiology nurses and physiotherapists.
Primary Outcome Measures
NameTimeMethod
Peak oxygen consumption (VO2)changeBaseline, 3, 6 months

Difference in the interval changes from baseline to 3 months and 6 months in peak VO2 comparing Experimental group with control.

Secondary Outcome Measures
NameTimeMethod
oxygen consumption (VO2) at anaerobic thresholdBaseline, 3, 6 months

Difference in the interval changes from baseline to 3 months and 6 months in VO2 at anaerobic threshold comparing Experimental group with control.

Peak metabolic equivalent (MET) changeBaseline, 3, 6 months

Difference in the interval changes from baseline to 3 months and 6 months in peak metabolic equivalent (MET) change comparing experimental group with control.

The MOS item short form health survey(SF-36)Baseline, 3, 6 months

Difference in the interval changes from baseline to 3 months and 6 months in The MOS item short form health survey(SF-36) comparing experimental group with control.

Ventilatory efficiency (VE/VCO2 slope) changeBaseline, 3, 6 months

Difference in the interval changes from baseline to 3 months and 6 months in Ventilatory efficiency (VE/VCO2 slope) comparing experimental group with control.

Body mass index(BMI)changeBaseline, 3, 6 months

Difference in the interval changes from baseline to 3 months and 6 months in Body mass index(BMI)comparing experimental group with control. BMI is the value obtained by dividing body weight by height square (weight in kilograms, height in meters). BMI is a standard commonly used in the world to measure the degree of obesity and health of the human body.

LVEF changeBaseline, 3, 6 months

Difference in the interval changes from baseline to 3 months and 6 months in LVEF comparing experimental group with control.

Oxygen uptake related to work rate(ΔVO2/ΔWR)changeBaseline, 3, 6 months

Difference in the interval changes from baseline to 3 months and 6 months in Oeygen uptake related to work rate(ΔVO2/ΔWR)comparing experimental group with control.

Peak /AT Oxygen Pulse (O2-Pulse)changeBaseline, 3, 6 months

Difference in the interval changes from baseline to 3 months and 6 months in Peak /AT Oxygen Pulse (O2-Pulse) comparing experimental group with control.

Heart rate variabilityBaseline, 3, 6 months

Difference in the interval changes from baseline to 3 months and 6 months in Heart rate variability comparing experimental group with control.

NT-proBNP(pg/ml)Baseline, 3, 6 months

Difference in the interval changes from baseline to 3 months and 6 months in NT-proBNP comparing Experimental group with control.

The occurrence and composite of major adverse cardiac events (MACE)3, 6 months

Major adverse cardiac events (MACE) included all-cause mortality, non-fatal myocardial infarction and coronary revascularisation. we check the outcome in 3 months and 6 months.

Trial Locations

Locations (1)

RenJi Hospital, Shanghai JiaoTong University, School of Medicine

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath